1 Introduction to Research & Analysis Reports
1.1 Ophthalmology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ophthalmology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ophthalmology Drugs Overall Market Size
2.1 Global Ophthalmology Drugs Market Size: 2022 VS 2029
2.2 Global Ophthalmology Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Ophthalmology Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Ophthalmology Drugs Players in Global Market
3.2 Top Global Ophthalmology Drugs Companies Ranked by Revenue
3.3 Global Ophthalmology Drugs Revenue by Companies
3.4 Global Ophthalmology Drugs Sales by Companies
3.5 Global Ophthalmology Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Ophthalmology Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Ophthalmology Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ophthalmology Drugs Players in Global Market
3.8.1 List of Global Tier 1 Ophthalmology Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Ophthalmology Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Ophthalmology Drugs Market Size Markets, 2022 & 2029
4.1.2 Gels
4.1.3 Eye Solutions
4.1.4 Capsules & Tablets
4.1.5 Eye Drops
4.1.6 Ointments
4.2 By Type – Global Ophthalmology Drugs Revenue & Forecasts
4.2.1 By Type – Global Ophthalmology Drugs Revenue, 2018-2023
4.2.2 By Type – Global Ophthalmology Drugs Revenue, 2024-2029
4.2.3 By Type – Global Ophthalmology Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Ophthalmology Drugs Sales & Forecasts
4.3.1 By Type – Global Ophthalmology Drugs Sales, 2018-2023
4.3.2 By Type – Global Ophthalmology Drugs Sales, 2024-2029
4.3.3 By Type – Global Ophthalmology Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Ophthalmology Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Ophthalmology Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.2 By Application – Global Ophthalmology Drugs Revenue & Forecasts
5.2.1 By Application – Global Ophthalmology Drugs Revenue, 2018-2023
5.2.2 By Application – Global Ophthalmology Drugs Revenue, 2024-2029
5.2.3 By Application – Global Ophthalmology Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Ophthalmology Drugs Sales & Forecasts
5.3.1 By Application – Global Ophthalmology Drugs Sales, 2018-2023
5.3.2 By Application – Global Ophthalmology Drugs Sales, 2024-2029
5.3.3 By Application – Global Ophthalmology Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Ophthalmology Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Ophthalmology Drugs Market Size, 2022 & 2029
6.2 By Region – Global Ophthalmology Drugs Revenue & Forecasts
6.2.1 By Region – Global Ophthalmology Drugs Revenue, 2018-2023
6.2.2 By Region – Global Ophthalmology Drugs Revenue, 2024-2029
6.2.3 By Region – Global Ophthalmology Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Ophthalmology Drugs Sales & Forecasts
6.3.1 By Region – Global Ophthalmology Drugs Sales, 2018-2023
6.3.2 By Region – Global Ophthalmology Drugs Sales, 2024-2029
6.3.3 By Region – Global Ophthalmology Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Ophthalmology Drugs Revenue, 2018-2029
6.4.2 By Country – North America Ophthalmology Drugs Sales, 2018-2029
6.4.3 US Ophthalmology Drugs Market Size, 2018-2029
6.4.4 Canada Ophthalmology Drugs Market Size, 2018-2029
6.4.5 Mexico Ophthalmology Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Ophthalmology Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Ophthalmology Drugs Sales, 2018-2029
6.5.3 Germany Ophthalmology Drugs Market Size, 2018-2029
6.5.4 France Ophthalmology Drugs Market Size, 2018-2029
6.5.5 U.K. Ophthalmology Drugs Market Size, 2018-2029
6.5.6 Italy Ophthalmology Drugs Market Size, 2018-2029
6.5.7 Russia Ophthalmology Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Ophthalmology Drugs Market Size, 2018-2029
6.5.9 Benelux Ophthalmology Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Ophthalmology Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Ophthalmology Drugs Sales, 2018-2029
6.6.3 China Ophthalmology Drugs Market Size, 2018-2029
6.6.4 Japan Ophthalmology Drugs Market Size, 2018-2029
6.6.5 South Korea Ophthalmology Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Ophthalmology Drugs Market Size, 2018-2029
6.6.7 India Ophthalmology Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Ophthalmology Drugs Revenue, 2018-2029
6.7.2 By Country – South America Ophthalmology Drugs Sales, 2018-2029
6.7.3 Brazil Ophthalmology Drugs Market Size, 2018-2029
6.7.4 Argentina Ophthalmology Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Ophthalmology Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Ophthalmology Drugs Sales, 2018-2029
6.8.3 Turkey Ophthalmology Drugs Market Size, 2018-2029
6.8.4 Israel Ophthalmology Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Ophthalmology Drugs Market Size, 2018-2029
6.8.6 UAE Ophthalmology Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Allergan
7.1.1 Allergan Company Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Ophthalmology Drugs Major Product Offerings
7.1.4 Allergan Ophthalmology Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Allergan Key News & Latest Developments
7.2 Aerie Pharmaceuticals
7.2.1 Aerie Pharmaceuticals Company Summary
7.2.2 Aerie Pharmaceuticals Business Overview
7.2.3 Aerie Pharmaceuticals Ophthalmology Drugs Major Product Offerings
7.2.4 Aerie Pharmaceuticals Ophthalmology Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Aerie Pharmaceuticals Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Ophthalmology Drugs Major Product Offerings
7.3.4 Pfizer Ophthalmology Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Valeant
7.4.1 Valeant Company Summary
7.4.2 Valeant Business Overview
7.4.3 Valeant Ophthalmology Drugs Major Product Offerings
7.4.4 Valeant Ophthalmology Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Valeant Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Ophthalmology Drugs Major Product Offerings
7.5.4 Bayer Ophthalmology Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Genentech
7.6.1 Genentech Company Summary
7.6.2 Genentech Business Overview
7.6.3 Genentech Ophthalmology Drugs Major Product Offerings
7.6.4 Genentech Ophthalmology Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Genentech Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Ophthalmology Drugs Major Product Offerings
7.7.4 Novartis Ophthalmology Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Regeneron
7.8.1 Regeneron Company Summary
7.8.2 Regeneron Business Overview
7.8.3 Regeneron Ophthalmology Drugs Major Product Offerings
7.8.4 Regeneron Ophthalmology Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Regeneron Key News & Latest Developments
7.9 Takeda
7.9.1 Takeda Company Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Ophthalmology Drugs Major Product Offerings
7.9.4 Takeda Ophthalmology Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Takeda Key News & Latest Developments
7.10 Santen Pharmaceutical
7.10.1 Santen Pharmaceutical Company Summary
7.10.2 Santen Pharmaceutical Business Overview
7.10.3 Santen Pharmaceutical Ophthalmology Drugs Major Product Offerings
7.10.4 Santen Pharmaceutical Ophthalmology Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Santen Pharmaceutical Key News & Latest Developments
8 Global Ophthalmology Drugs Production Capacity, Analysis
8.1 Global Ophthalmology Drugs Production Capacity, 2018-2029
8.2 Ophthalmology Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Ophthalmology Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ophthalmology Drugs Supply Chain Analysis
10.1 Ophthalmology Drugs Industry Value Chain
10.2 Ophthalmology Drugs Upstream Market
10.3 Ophthalmology Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ophthalmology Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の眼科用治療薬市場予測2023-2029：ジェル、点眼液、カプセル・錠剤、点眼薬、軟膏 |
| 【英語タイトル】Ophthalmology Drugs Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5834 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：73 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の眼科用治療薬市場規模と予測を収録しています。・世界の眼科用治療薬市場：売上、2018年-2023年、2024年-2029年 ・世界の眼科用治療薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の眼科用治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ジェル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 眼科用治療薬のグローバル主要企業は、Allergan、 Aerie Pharmaceuticals、 Pfizer、 Valeant、 Bayer、 Genentech、 Novartis、 Regeneron、 Takeda、 Santen Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、眼科用治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の眼科用治療薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の眼科用治療薬市場：タイプ別市場シェア、2022年 ・ジェル、点眼液、カプセル・錠剤、点眼薬、軟膏 世界の眼科用治療薬市場：用途別、2018年-2023年、2024年-2029年 世界の眼科用治療薬市場：用途別市場シェア、2022年 ・病院、小売薬局 世界の眼科用治療薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の眼科用治療薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における眼科用治療薬のグローバル売上、2018年-2023年 ・主要企業における眼科用治療薬のグローバル売上シェア、2022年 ・主要企業における眼科用治療薬のグローバル販売量、2018年-2023年 ・主要企業における眼科用治療薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Allergan、 Aerie Pharmaceuticals、 Pfizer、 Valeant、 Bayer、 Genentech、 Novartis、 Regeneron、 Takeda、 Santen Pharmaceutical ************************************************************* ・調査・分析レポートの概要 眼科用治療薬市場の定義 市場セグメント 世界の眼科用治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の眼科用治療薬市場規模 世界の眼科用治療薬市場規模：2022年 VS 2029年 世界の眼科用治療薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの眼科用治療薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の眼科用治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ジェル、点眼液、カプセル・錠剤、点眼薬、軟膏 眼科用治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、小売薬局 眼科用治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別眼科用治療薬市場規模 2022年と2029年 地域別眼科用治療薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Allergan、 Aerie Pharmaceuticals、 Pfizer、 Valeant、 Bayer、 Genentech、 Novartis、 Regeneron、 Takeda、 Santen Pharmaceutical ... |
Drugs for ophthalmology, which are used to treat eye conditions and eye diseases such as glaucoma, conjunctivitis and others.
This report aims to provide a comprehensive presentation of the global market for Ophthalmology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmology Drugs. This report contains market size and forecasts of Ophthalmology Drugs in global, including the following market information:
Global Ophthalmology Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Ophthalmology Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Ophthalmology Drugs companies in 2022 (%)
The global Ophthalmology Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Gels Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ophthalmology Drugs include Allergan, Aerie Pharmaceuticals, Pfizer, Valeant, Bayer, Genentech, Novartis, Regeneron and Takeda, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ophthalmology Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmology Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ophthalmology Drugs Market Segment Percentages, by Type, 2022 (%)
Gels
Eye Solutions
Capsules & Tablets
Eye Drops
Ointments
Global Ophthalmology Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ophthalmology Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Global Ophthalmology Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ophthalmology Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmology Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ophthalmology Drugs revenues share in global market, 2022 (%)
Key companies Ophthalmology Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Ophthalmology Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Aerie Pharmaceuticals
Pfizer
Valeant
Bayer
Genentech
Novartis
Regeneron
Takeda
Santen Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ophthalmology Drugs, market overview.
Chapter 2: Global Ophthalmology Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Ophthalmology Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ophthalmology Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の眼科用治療薬市場予測2023-2029：ジェル、点眼液、カプセル・錠剤、点眼薬、軟膏] (コード：MMG23JU5834)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の眼科用治療薬市場予測2023-2029：ジェル、点眼液、カプセル・錠剤、点眼薬、軟膏]についてメールでお問い合わせ |
